Stem Cells May Move to the Front Line against Multiple Sclerosis
Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.
To read more about the article, click the following link:
Stem Cells May Move to the Front Line against Multiple Sclerosis
